Details of the Drug

General Information of Drug (ID: DMKD6IV)

Drug Name
GSK3888130?
Indication
Disease Entry ICD 11 Status REF
Multiple sclerosis 8A40 Phase 1 [1]
Drug Type
Antibody
Cross-matching ID
TTD ID
DPI9N4

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interleukin-7 (IL7) TT8FRMO IL7_HUMAN Not Available [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT05131971) A Randomized, Double-Blind, Placebo Controlled, Single Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK3888130B in Healthy Participants Aged 18-55 Inclusive. U.S.National Institutes of Health.
2 Clinical pipeline report, company report or official report of GlaxoSmithKline